Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
0.7516
-0.0704 (-8.56%)
At close: Dec 12, 2025, 4:00 PM EST
0.7401
-0.0115 (-1.53%)
After-hours: Dec 12, 2025, 7:57 PM EST
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $8.11 million as of December 12, 2025. Its market cap has increased by 56.26% in one year.
Market Cap
8.11M
Enterprise Value
-2.37M
1-Year Change
56.26%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $8.11M, an increase of 63.17%. That is a compound annual growth rate of 4.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 14, 2025 | 7.50M | -32.30% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | 67.08M | 364.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |